PROFUSA, INC. Cash and Restricted Cash
PROFUSA, INC. (PFSA) had Cash and Restricted Cash of $719.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-19
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $719.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $375.00K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.78M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.01M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $719.00K 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $375.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.78M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $3.01M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $39.00K 10-Q · filed 2026-08-19 | $1.75K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $19.00K 10-Q · filed 2026-05-15 | $18.45K 10-Q · filed 2025-06-13 |
| 2024-12-31 | $191.00K 10-Q · filed 2026-08-19 | $16.20K 10-K · filed 2025-03-31 |
| 2024-09-30 | $140.00K 10-Q · filed 2025-11-19 | $533.00 10-Q · filed 2024-12-17 |
| 2024-06-30 | $6.50K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $5.31K 10-Q · filed 2025-06-13 | |
| 2023-12-31 | $142.00K S-1/A · filed 2026-05-01 | $4.52K 10-K · filed 2024-02-26 |
| 2023-09-30 | $17.34K 10-Q · filed 2024-12-17 | |
| 2023-06-30 | $5.81K 10-Q · filed 2024-11-15 | |
| 2023-03-31 | $55.61K 10-Q · filed 2024-10-09 | |
| 2022-12-31 | $193.49K 10-K · filed 2025-03-31 | |
| 2022-09-30 | $372.87K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $480.73K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $510.88K 10-Q · filed 2023-05-17 | |
| 2021-12-31 | $741.23K 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |